alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 87, Number 82 (Thursday, April 28, 2022)]
[Notices]
[Page 25304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-09056]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-994]


Bulk Manufacturer of Controlled Substances Application: Research 
Triangle Institute

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Research Triangle Institute has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
June 27, 2022. Such persons may also file a written request for a 
hearing on the application on or before June 27, 2022.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March 11, 2022, Research Triangle Institute, 3040 
East Cornwallis Road Hermann Building, Room 106, Research Triangle 
Park, North Carolina 27709, applied to be registered as a bulk 
manufacturer of the following basic class of controlled substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols..................    7370   I
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substance synthetically only for distribution to its customers for 
research and analytical reference standards. No other activities for 
this drug code are authorized for this registration.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-09056 Filed 4-27-22; 8:45 am]
BILLING CODE P
Opinion issued April 2 , 2024

In The 

## Court of Appeals For The 

## First District of Texas

———————————— NO. 01
- 24
- 00022
- CR

——————————— DAMIAN JAWON HEARD , Appella nt

V. THE STATE OF TEXAS , Appell e e
On Appeal from the 263rd District Court

Harris County, Texas Trial Court Ca se No. 1792073

MEMORANDUM OPINION Appellant’s appointed counsel has filed a notice that this Court lacks jurisdiction. We agree and dismiss the appeal. The clerk’s record indicates that the trial court entered an order of deferred adjudication on December 18, 2023, in accordance with a plea bargain. The2

certification of defendant’s right to appeal indicates that this is a plea

- bargain case and appellant has no right of appeal. No other appealable order appears in the clerk’s record. Because appellant h as no right of appeal, we must dismiss th e appeal s for lack of jurisdiction

. See Chavez v. State , 183 S.W.3d 675, 680 (Tex. Crim. App. 2006). Accordingly , we dismiss this appeal. Any pending motions are dismissed as
moot. PER CURIAM Panel consists of Justices Goodman, Landau, and Hightower. Do Not Publish. T EX
. R. A PP
. P. 47.2(b).
Troy ARNAUD, petitioner, v. Darrel VANNOY, Warden.

No. 18-8113.

Supreme Court of the United States

March 25, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
I

106TH CONGRESS

1ST SESSION H. R. 1404

To amend title 11 of the United States Code to include the earned income

credit in property that the debtor may elect to exempt from the estate.

IN THE HOUSE OF REPRESENTATIVES

APRIL 14, 1999

Mr. BROWN of Ohio introduced the following bill; which was referred to the

Committee on the Judiciary

A BILL

To amend title 11 of the United States Code to include

the earned income credit in property that the debtor

may elect to exempt from the estate.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. AMENDMENTS.

4 Section 522(d)(10) of title 11, United States Code,

5 is amended—

6 (1) in subparagraph (E) by striking the period

7 at the end and inserting ‘‘; or’’, and

8 (2) by adding at the end the following:

9 ‘‘(F)(i) any refund of tax imposed by sub10 title A of the Internal Revenue Code of 1986
2

•HR 1404 IH

1 for any taxable year to the extent that the

2 amount of the refund does not exceed the credit

3 allowed by section 32 of such Code for such

4 year, and

5 ‘‘(ii) any advance payment of such credit

6 under section 3507 of such Code.’’.

7 SEC. 2. EFFECTIVE DATE; APPLICATION OF AMENDMENTS.

8 (a) EFFECTIVE DATE.—Except as provided in sub9 section (b), this Act and the amendments made by section

10 1 shall take effect on the date of the enactment of this

11 Act.

12 (b) APPLICATION OF AMENDMENTS.—The amend13 ments made by this Act shall apply only with respect to

14 cases commenced under title 11 of the United States Code

15 on or after the date of the enactment of this Act.

Æ
```
 
 
CRUDE OIL, LIGHT SWEET - ICE FUTURES EUROPE                          Code-067411
OPTION AND FUTURES COMBINED POSITIONS AS OF 12/14/10          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
(CONTRACTS OF 1,000 BARRELS)                         OPEN INTEREST:      528,868
COMMITMENTS
  72,586   15,503  129,399  309,014  368,915  510,999  513,818   17,869   15,050

CHANGES FROM 12/07/10 (CHANGE IN OPEN INTEREST:    -14,350)
   7,873   -4,214    1,466  -15,939   -3,433   -6,600   -6,180   -7,750   -8,170

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    13.7      2.9     24.5     58.4     69.8     96.6     97.2      3.4      2.8

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      118)
      42       10       44       60       63      112      108
```

----

Updated December 17, 2010
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from Swift Energy
Pension Assets Partnership  1989-B,  Ltd.'s  balance  sheet and  statement  of
operations contained in its Form 10-Q for the quarter ended March 31, 2000 and
is qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   MAR-31-2000
<CASH>                                         1,023
<SECURITIES>                                   0
<RECEIVABLES>                                  97,641
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               98,664
<PP&E>                                         3,753,111
<DEPRECIATION>                                 (3,145,015)
<TOTAL-ASSETS>                                 706,760
<CURRENT-LIABILITIES>                          6,103
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     700,657
<TOTAL-LIABILITY-AND-EQUITY>                   706,760
<SALES>                                        77,447
<TOTAL-REVENUES>                               77,518
<CGS>                                          0
<TOTAL-COSTS>                                  23,446<F1>
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                33,623
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            33,623
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   33,623
<EPS-BASIC>                                    0
<EPS-DILUTED>                                  0
<FN>
<F1>Includes  lease  operating  expenses,  production  taxes  and  depreciation,
depletion and  amortization  expense.  Excludes general and  administrative  and
interest expense.
</FN>



</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

                    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial                           ( print page 25648)                        property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                

*Name of Committee:*                         National Institute on Aging Special Emphasis Panel; Cell-specific liquid phase separation in AD.                    

*Date:*                         May 19-20, 2022.                    

*Time:*                         10:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Joshua Jin-Hyouk Park, Ph.D., Scientific Review Officer, Scientific Review Branch, NIA (National Institute on Aging), Gateway Building Rm. 2W200, 7201 Wisconsin Ave., Bethesda, MD 20892, (301) 496-6208,                         *joshua.park4@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)

Dated: April 27, 2022.

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-09385 Filed 4-29-22; 8:45 am]

BILLING CODE 4140-01-P
IN THE DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FIFTH DISTRICT

 NOT FINAL UNTIL TIME EXPIRES TO

 FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

OSCEOLA REGIONAL HOSPITAL, 

D/B/A OSCEOLA REGIONAL 

MEDICAL CENTER,

Petitioner,

v. Case No. 5D17-4097

ASHLEY CALZADA AND JUAN L. 

CALZADA, INDIVIDUALLY AND 

O/B/O J.L.C.O., A CHILD, ERIC 

FRENDAK, CRNA, OSCEOLA 

OB/GYN, MICHAEL R. DENARDIS, 

D.O., OB HOSPITALIST GROUP, LLC, 

EZER A. OJEDA, M.D., ET AL.,

Respondents.

________________________________/

Opinion filed July 6, 2018

Petition for Certiorari Review of Order 

from the Circuit Court for Osceola County,

Margaret H. Schreiber, Judge.

Jason M. Azzarone, David S. Nelson, and 

Louis J. La Cava, of La Cava & Jacobson, 

P.A., Tampa, for Petitioner.

Heather M. Kolinsky, of Law Office of 

Chad A. Barr, P.A., Altamonte Springs, for 

Respondents Ashley Calzada and Juan 

Calzada, individually and on behalf of 

J.L.C.O., a Child.

No Appearance for other Respondents.
2

PER CURIAM.

Osceola Regional Hospital, d/b/a Osceola Regional Medical Center (“Osceola 

Hospital”), a defendant in a medical malpractice action brought by Ashley and Juan 

Calzada, seeks certiorari review of an order denying its motion to dismiss complaint. In 

its motion, Osceola Hospital alleged, inter alia, that the Calzadas had failed to comply 

with certain presuit investigation requirements applicable to medical malpractice cases 

under chapter 766, Florida Statutes (2013), with regard to their claims that Osceola 

Hospital was liable for the actions of three identified nurses. Because the trial court 

denied the motion without making necessary findings, we grant the petition.

Osceola Hospital’s motion required the trial court to determine whether the 

Calzadas complied with chapter 766. However, after conducting a non-evidentiary 

hearing, the trial court simply denied the motion without explanation. By doing so, the 

trial court “effected a denial of the procedural safeguards of chapter 766 for which 

certiorari relief is appropriate.” PP Transition, LP v. Munson, 232 So. 3d 515, 516 (Fla. 

2d DCA 2017) (granting certiorari relief where trial court denied hospital’s motion to 

dismiss without making express findings on plaintiffs’ compliance with presuit 

investigation requirements applicable to medical malpractice cases); see also Martin 

Mem’l Med. Ctr., Inc. v. Herber, 984 So. 2d 661, 663 (Fla. 4th DCA 2008) (holding that 

trial court departed from essential requirements of law by failing to determine whether 

patient conducted reasonable investigation and whether her claim rested on reasonable 
3

basis). On remand, the trial court shall make express findings as to whether the 

Calzadas complied with chapter 766’s presuit requirements.1

PETITION GRANTED.

SAWAYA, TORPY AND EVANDER, JJ., concur.

 

1 Our decision does not preclude the trial court from addressing the Calzadas’ 

claim that they were excused from providing a corroborating affidavit because of Osceola 

Hospital’s alleged failure to timely provide requested medical records pursuant to section 

766.204, Florida Statutes (2013).
Michael MARRANCA, petitioner, v. Valery LOYTSKER.

No. 17-1571.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Superior Court of New Jersey, Appellate Division denied.
Juan Bautista Rosas CUELLAR, petitioner, v. UNITED STATES

Daniel Larios-Villatoro, petitioner, v. United States.

No. 18-7082.

Supreme Court of the United States

Feb. 19, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
Janice SMETS, petitioner, v. Heather WILSON, Secretary of the Air Force.

No. 18-1058.

Supreme Court of the United States

April 15, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Scott Ash James ZIRUS, petitioner, v. Sharon Faye KELLER, et al.

No. 18-7476.

Supreme Court of the United States

March 25, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              JUN-30-2000
<PERIOD-START>                                 JUL-01-1999
<PERIOD-END>                                   MAR-31-2000
<CASH>                                         79,267
<SECURITIES>                                   0
<RECEIVABLES>                                  2,304,767
<ALLOWANCES>                                   31,000
<INVENTORY>                                    0
<CURRENT-ASSETS>                               3,984,158
<PP&E>                                         2,040,433
<DEPRECIATION>                                 1,197,000
<TOTAL-ASSETS>                                 4,881,115
<CURRENT-LIABILITIES>                          11,492,382
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    699
<COMMON>                                       18,739
<OTHER-SE>                                     (7,397,215)
<TOTAL-LIABILITY-AND-EQUITY>                   4,881,115
<SALES>                                        15,825,658
<TOTAL-REVENUES>                               15,825,658
<CGS>                                          10,992,254
<TOTAL-COSTS>                                  10,992,254
<OTHER-EXPENSES>                               7,257,019
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             250,952
<INCOME-PRETAX>                                (2,674,567)
<INCOME-TAX>                                   6,658
<INCOME-CONTINUING>                            (2,681,225)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (2,681,225)
<EPS-BASIC>                                  (.19)
<EPS-DILUTED>                                  (.19)



</TABLE>
Steven Anthony BUTLER, petitioner, v. Lorie DAVIS, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

No. 18-7091.

Supreme Court of the United States

April 15, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
Stephen Anthony MARQUEZ, petitioner, v. Lorie DAVIS, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

No. 18-6885.

Supreme Court of the United States

Feb. 19, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
Exhibit 12.2
**Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
**Principal Financial Officer Certification**
I, Enrico D’Onofrio, certify that:
1. I have reviewed this annual report on Form 20-F of Ducati Motor HoldingS.p.A.; 2. Based on my knowledge, this report does not contain any untrue statementof a material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by thisreport; 3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows ofthe company as of, and for, the periods presented in this report; 4. The company’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company andhave:
(a) designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to thecompany, including its consolidated subsidiaries, is made known tous by others within those entities, particularly during the periodin which this report is being prepared;
(b) evaluated the effectiveness of the company’s disclosurecontrols and procedures and presented in this report ourconclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this reportbased on such evaluation; and
(c) disclosed in this report any change in the company’s internalcontrol over financial reporting that occurred during the periodcovered by the annual report that has materially affected, or isreasonably likely to materially affect, the company’s internalcontrol over financial reporting; and
5. The company’s other certifying officer and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, tothe company’s auditors and the audit committee of the company’s board ofdirectors (or persons performing the equivalent functions):
(a) all significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the company’sability to record, process, summarize and report financialinformation; and
(b) any fraud, whether or not material, that involves management orother employees who have a significant role in the company’sinternal control over financial reporting.
Date: June 30, 2004                                                    /s/ Enrico D'Onofrio   Manager of Finance
```
 
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
FUTURES ONLY POSITIONS AS OF 05/10/11                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      228,037
COMMITMENTS
  29,676   41,147   40,290  127,440  126,989  197,406  208,426   30,631   19,611

CHANGES FROM 05/03/11 (CHANGE IN OPEN INTEREST:     13,029)
     873      744   -1,251    8,799   10,271    8,421    9,764    4,608    3,265

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    13.0     18.0     17.7     55.9     55.7     86.6     91.4     13.4      8.6

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      122)
      41       31       47       28       30      102       93
```

----

Updated May 13, 2010